Transcriptional activity of inverted terminal repeats of various human adenovirus serotypes

References

1. Babiss, L. E., Bennett, A., Friedman, J. M. & Darnell, J. E., Jr(1986). DNase I-hypersensitive sites in the 5′-flanking region of the rat serum albumin gene: correlation between chromatin structure and transcriptional activity. Proc Natl Acad Sci U S A 83, 6504–6508.[CrossRef] [Google Scholar]
2. Bromberg, J. S., Debruyne, L. A. & Qin, L.(1998). Interactions between the immune system and gene therapy vectors: bidirectional regulation of response and expression. Adv Immunol 69, 353–409. [Google Scholar]
3. Brunetti-Pierri, N., Stapleton, G. E., Palmer, D. J., Zuo, Y., Mane, V. P., Finegold, M. J., Beaudet, A. L., Leland, M. M., Mullins, C. E. & other authors(2007). Pseudo-hydrodynamic delivery of helper-dependent adenoviral vectors into non-human primates for liver-directed gene therapy. Mol Ther 15, 732–740. [Google Scholar]
4. Ehrhardt, A., Xu, H., Huang, Z., Engler, J. A. & Kay, M. A.(2005). A direct comparison of two nonviral gene therapy vectors for somatic integration: in vivo evaluation of the bacteriophage integrase φC31 and the Sleeping Beauty transposase. Mol Ther 11, 695–706.[CrossRef] [Google Scholar]
5. Harui, A., Suzuki, S., Kochanek, S. & Mitani, K.(1999). Frequency and stability of chromosomal integration of adenovirus vectors. J Virol 73, 6141–6146. [Google Scholar]
6. Hatfield, L. & Hearing, P.(1991). Redundant elements in the adenovirus type 5 inverted terminal repeat promote bidirectional transcription in vitro and are important for virus growth in vivo. Virology 184, 265–276.[CrossRef] [Google Scholar]
7. Hearing, P., Samulski, R. J., Wishart, W. L. & Shenk, T.(1987). Identification of a repeated sequence element required for efficient encapsidation of the adenovirus type 5 chromosome. J Virol 61, 2555–2558. [Google Scholar]
8. Imler, J. L., Dupuit, F., Chartier, C., Accart, N., Dieterle, A., Schultz, H., Puchelle, E. & Pavirani, A.(1996). Targeting cell-specific gene expression with an adenovirus vector containing the lacZ gene under the control of the CFTR promoter. Gene Ther 3, 49–58. [Google Scholar]
9. Ishino, M., Sawada, Y., Yaegashi, T., Demura, M. & Fujinaga, K.(1987). Nucleotide sequence of the adenovirus type 40 inverted terminal repeat: close relation to that of adenovirus type 5. Virology 156, 414–416.[CrossRef] [Google Scholar]
10. Maucksch, C., Aneja, M. K., Hennen, E., Bohla, A., Hoffmann, F., Elfinger, M., Rosenecker, J. & Rudolph, C.(2008). Cell type differences in activity of the Streptomyces bacteriophage φC31 integrase. Nucleic Acids Res 36, 5462–5471.[CrossRef] [Google Scholar]
11. Morral, N., Parks, R. J., Zhou, H., Langston, C., Schiedner, G., Quinones, J., Graham, F. L., Kochanek, S. & Beaudet, A. L.(1998). High doses of a helper-dependent adenoviral vector yield supraphysiological levels of α₁-antitrypsin with negligible toxicity. Hum Gene Ther 9, 2709–2716.[CrossRef] [Google Scholar]
12. Proudfoot, N. J.(1986). Transcriptional interference and termination between duplicated α-globin gene constructs suggests a novel mechanism for gene regulation. Nature 322, 562–565.[CrossRef] [Google Scholar]
13. Rubinchik, S., Lowe, S., Jia, Z., Norris, J. & Dong, J.(2001). Creation of a new transgene cloning site near the right ITR of Ad5 results in reduced enhancer interference with tissue-specific and regulatable promoters. Gene Ther 8, 247–253.[CrossRef] [Google Scholar]
14. Sawada, Y., Ojima, S., Shimojo, H., Shiroki, K. & Fujinaga, K.(1979). Transforming DNA sequences in rat cells transformed by DNA fragments of highly oncogenic human adenovirus type 12. J Virol 32, 379–385. [Google Scholar]
15. Shi, Q., Wang, Y. & Worton, R.(1997). Modulation of the specificity and activity of a cellular promoter in an adenoviral vector. Hum Gene Ther 8, 403–410.[CrossRef] [Google Scholar]
16. Stephen, S. L., Sivanandam, V. G. & Kochanek, S.(2008). Homologous and heterologous recombination between adenovirus vector DNA and chromosomal DNA. J Gene Med 10, 1176–1189.[CrossRef] [Google Scholar]
17. Sutter, D., Westphal, M. & Doerfler, W.(1978). Patterns of integration of viral DNA sequences in the genomes of adenovirus type 12-transformed hamster cells. Cell 14, 569–585.[CrossRef] [Google Scholar]
18. Tolun, A., Alestrom, P. & Pettersson, U.(1979). Sequence of inverted terminal repetitions from different adenoviruses: demonstration of conserved sequences and homology between SA7 termini and SV40 DNA. Cell 17, 705–713.[CrossRef] [Google Scholar]
19. Xing, L. & Tikoo, S. K.(2005). Promoter activity of left inverted terminal repeat and downstream sequences of porcine adenovirus type 3. Virus Res 109, 51–58.[CrossRef] [Google Scholar]
20. Xing, L. & Tikoo, S. K.(2006). E1A promoter of bovine adenovirus type 3. J Gen Virol 87, 3539–3544.[CrossRef] [Google Scholar]
21. Yamamoto, M., Davydova, J., Takayama, K., Alemany, R. & Curiel, D. T.(2003). Transcription initiation activity of adenovirus left-end sequence in adenovirus vectors with E1 deleted. J Virol 77, 1633–1637.[CrossRef] [Google Scholar]
22. Yang, Y., Li, Q., Ertl, H. C. & Wilson, J. M.(1995). Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses. J Virol 69, 2004–2015. [Google Scholar]